
    
      The duration of the study per patient will be up to 3 years that will consist of a 14-day
      screening period, that may be extended to up to 4 weeks in pre-specified situations, a
      25-week treatment period, a 120-week extension period, and a 4-week post-treatment
      observation period.
    
  